TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,877,493 | +0.5% | 1,802,036 | +2.1% | 0.54% | -2.7% |
| Q2 2023 | $27,733,159 | -7.4% | 1,765,319 | -2.9% | 0.56% | -12.1% |
| Q1 2023 | $29,960,175 | +1521.8% | 1,817,972 | +1435.2% | 0.64% | +1123.1% |
| Q4 2022 | $1,847,352 | -92.4% | 118,420 | -93.7% | 0.05% | -91.8% |
| Q3 2022 | $24,267,000 | -14.5% | 1,871,043 | -7.5% | 0.64% | -8.4% |
| Q2 2022 | $28,396,000 | -6.0% | 2,022,547 | -4.1% | 0.69% | +7.1% |
| Q1 2022 | $30,213,000 | +26.7% | 2,109,846 | +20.6% | 0.65% | +24.4% |
| Q4 2021 | $23,850,000 | -27.8% | 1,749,763 | -13.2% | 0.52% | -27.5% |
| Q3 2021 | $33,019,000 | -5.8% | 2,015,824 | -3.2% | 0.72% | -8.0% |
| Q2 2021 | $35,044,000 | +8.5% | 2,082,235 | +18.3% | 0.78% | +1.8% |
| Q1 2021 | $32,311,000 | +6.9% | 1,760,848 | +5.9% | 0.76% | -1.8% |
| Q4 2020 | $30,235,000 | +16.5% | 1,663,081 | +14.3% | 0.78% | -13.2% |
| Q3 2020 | $25,958,000 | -13.4% | 1,455,039 | -12.9% | 0.90% | -1.6% |
| Q2 2020 | $29,958,000 | +9.7% | 1,670,809 | -7.1% | 0.91% | -4.5% |
| Q1 2020 | $27,298,000 | -19.2% | 1,798,239 | +5.0% | 0.96% | +18.8% |
| Q4 2019 | $33,804,000 | +6.6% | 1,713,349 | -7.0% | 0.80% | -2.0% |
| Q3 2019 | $31,704,000 | +33.3% | 1,843,235 | +37.2% | 0.82% | +54.7% |
| Q2 2019 | $23,778,000 | -21.0% | 1,343,416 | -9.0% | 0.53% | -24.2% |
| Q1 2019 | $30,087,000 | +76.4% | 1,477,015 | +45.7% | 0.70% | +61.1% |
| Q4 2018 | $17,053,000 | – | 1,013,882 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |